For CROs & Sponsors
Leverage Ryght's AI platform to streamline trial protocol writing, compare criteria, test against a global network, generate documents, and deploy studies efficiently, ensuring successful site activation and timely study completion.
For Research Sites
Join the Ryght Research Network for free AI-powered tools that enhance site efficiency, automate responses, assist with document writing, compare studies, and recommend new research opportunities.
For AI
Builders
Customize Ryght's research apps or develop your own with the Ryght SDK and No-code agent builder. With over 50 industry-specific APIs, develop AI apps easily, access vast online and private structured or unstructured datasets and transform your workflows with precision and speed.
"We've always been excited by the potential of AI to revolutionise our clinical trial workflows. Our partnership with Ryght will dramatically boost the accuracy, efficiency, and speed, while saving valuable time for sponsors, sites and participants."
Jon Anderson
CEO
nmible
"Ryght's cutting-edge technology aligns perfectly with our vision of using the power and potential of AI to transform healthcare data into novel, actionable insights that help clinicians practice more proactive care that delivers better patient outcomes."
Sean Cassidy
CEO
Lucem Health
"We are thrilled to collaborate with Ryght and utilize their GenAI platform to advance our clinical trial processes. Through the application of AI, we aim to further support our biotech clients to develop transformative therapeutics in areas of unmet need.”
Yvonne Lungershausen
CEO
Avance Clinical
"Ryght's cutting-edge technology aligns perfectly with our commitment to innovation that enables our customers to rapidly identify clinically qualified patients, leading to faster enrollment in clinical trials.
By harnessing the power of AI, we can continue to unlock new insights and accelerate access to clinical research."
Dave Levin
CEO
BEKhealth
"At the University of Adelaide, we are committed to advancing world-class research that addresses many of the challenges faced by society. By working together, we can leverage our collective expertise to develop innovative, responsible and tested solutions for better public health and other critical issues and bring Australia’s AI capabilities up to world-class standards where they belong.”
Professor Mark Hutchinson BSc, PhD
Interim Director of the Institute for Photonics and Advanced Sensing (IPAS)
Adelaide University
